Maria Rita Sessa

Maria Rita Sessa

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
GCGiorgio Costagliola
Giorgio Costagliola
MCM. Cosci o di Coscio
M. Cosci o di Coscio
BMB. Masini
B. Masini
FBFulvia baldinotti
Fulvia baldinotti
Maria CaligoMaria Caligo
Maria Caligo
Silvano BertelloniSilvano Bertelloni
Silvano Bertelloni

Verified
Journal Article
Open access
PDF file
SMSilvia Magno
Silvia Magno
GCGiovanni Ceccarini
Giovanni Ceccarini
Andrea BarisonAndrea Barison
Andrea Barison
IFIacopo Fabiani
Iacopo Fabiani
AGAlessandro Giacomina
Alessandro Giacomina
FSFerruccio Santini
Ferruccio Santini
Laminopathies are disorders caused by LMNA gene mutations, which selectively affect different tissues and organ systems, and present with heterogeneous clinical and pathological traits. The molecular mechanisms behind these clinical differences and tissue specificity have not been fully clarified. We herein examine the case of a patient carrying a heterozygous LMNA c.1634G>A (p.R545H) variant with a mild, transient myopathy, who was referred to our center for the suspicion of lipodystrophy. At physical examination, an abnormal distribution of subcutaneous fat was noticed, with fat accumulation in the anterior regions of the neck, resembling the fat distribution pattern of familial partial lipodystrophy type 2 (FPLD2). The R545H missense variant has been found at very low allelic frequency in public databases, and in silico analysis showed that this amino acid substitution is predicted to have a damaging role. Other patients carrying the heterozygous LMNA p.R545H allele have shown a marked clinical heterogeneity in terms of phenotypic body fat distribution and severity of organ system involvement. These findings indicate that the LMNA p.R545H heterozygous variant exhibits incomplete penetrance and highly variable expressivity. We hypothesized that additional genetic factors, epigenetic mechanisms, or environmental triggers might explain the variable expressivity of phenotypes among various patients.

25 September 2023 in Sexes
Verified
Journal Article
Open access
PDF file
GBGiulia Bertolucci
Giulia Bertolucci
NTNina Tyutyusheva
Nina Tyutyusheva
MSMargherita Sepich
Margherita Sepich
FBFulvia baldinotti
Fulvia baldinotti
Maria CaligoMaria Caligo
Maria Caligo
Silvano BertelloniSilvano Bertelloni
Silvano Bertelloni
Congenital adrenal hyperplasia (CAH) is a heterogeneous group of autosomal recessive disorders due to defects in adrenal steroid biosynthesis. In about 90% of patients, CAH is caused by pathogenetic variants in CYP21A2 gene, impairing the function of 21-hydroxylase (21-OH) enzyme. CAH can present as classical form (simple virilizing or salt wasting) or as non-classical form (NC-CAH). NC-CAH is due to pathogenetic variants in the CYP21A2 gene that result in 20–70% residual activity of 21-hydroxylase. Early diagnosis may be missed, mainly in childhood, jeopardizing long-term outcome. This paper will review some information on clinical findings, symptoms, diagnostic approaches, and treatments of NC-CAH in childhood, allowing better management and long-term outcome.

Verified
Journal Article
Open access
PDF file
DGDonatella Gilio
Donatella Gilio
CPCaterina Pelosini
Caterina Pelosini
SMSilvia Magno
Silvia Magno
JVJacopo Maria Venanzi
Jacopo Maria Venanzi
MDMarta Daniotti
Marta Daniotti
FSFerruccio Santini
Ferruccio Santini
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive disorder caused by mutations in the TYMP gene, typically characterized by severe and progressive gastrointestinal and neurological manifestations. Recent reports have identified a subset of patients presenting with generalized lipodystrophy and metabolic abnormalities, suggesting that adipose tissue involvement may be an underrecognized feature of the disease. Herein, we report the case of a 16-year-old female carrying a previously described homozygous TYMP variant (c.1178_1201dup; p.Arg393_Val400dup), who presented during adolescence with generalized lipodystrophy, insulin resistance, hypertriglyceridemia, hepatic steatosis, and other metabolic complications. At diagnosis, she exhibited no overt neurological or gastrointestinal symptoms; however, electroneurography revealed subclinical peripheral neuropathy. This case broadens the phenotypic spectrum of TYMP-related disease by documenting a lipodystrophic and metabolic presentation associated with the p.Arg393_Val400dup variant. While TYMP mutations have been linked to lipodystrophy in rare cases, this specific variant had previously been reported only in the context of classical MNGIE, with no documented evidence of adipose tissue or metabolic derangement. Our findings highlight the importance of considering TYMP involvement in the differential diagnosis of atypical lipodystrophy syndromes, particularly when features suggest underlying mitochondrial dysfunction.

8 July 2026 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
ACAlessandro Colitta
Alessandro Colitta
TMTessa Mazzarone
Tessa Mazzarone
SCSara Corsi
Sara Corsi
LPLucia Petrozzi
Lucia Petrozzi
AMAlessandro Mengozzi
Alessandro Mengozzi
GSGabriele Siciliano
Gabriele Siciliano

30 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMaria Rita Sessa
Maria Rita Sessa
LBLea Bianchi
Lea Bianchi
CNChiara Nencetti
Chiara Nencetti
AGAssuntina Del Grosso
Assuntina Del Grosso
DTDonatella Taddei
Donatella Taddei
PAPatrizia Agretti
Patrizia Agretti
Background Antimüllerian hormone (AMH) is a glycoprotein hormone mainly studied for its regulatory role in male sex differentiation. In both sexes AMH is secreted in serum and represents a specific marker of spermatogenesis in men and ovarian reserve in women. In order to substitute our current assay to measure serum AMH with a new assay to make easier laboratory routine and providing more reproducible and accurate results, the evaluation of a fully automated CLIA assay was performed. Methods AMH Gen II ELISA assay is an enzymatically amplified two-site manual immunoassay and Access AMH assay is a highly automated CLIA. To compare methods, 154 serum samples covering the range of values clinically observable, were used. Data statistical analysis was performed. The Access AMH assay was also partially validated by linear dilution analysis, matrix effect analysis and LoQ determination. Results Compared methods showed good relationship with a slight constant and proportional but not significant systematic error, and very similar results were obtained at all analyzed concentrations. The new method showed good linearity over a wide range of dilutions, matrix effect was insignificant and the LoQ was set to 0.01 ng/mL, in line with manufacturer claim. Conclusions The fully automated Access AMH immunoassay represents a robust, fast and precise alternative to manual AMH assay with improvement in evaluation of serum AMH levels in terms of analytical performances.